Delivery Order SPE2DB22D3501-SPE2DB25FUT72

Award Date 3/3/25
Potential Completion Date 3/4/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,387.56, is for the supply of Irbesartan 300 mg tablets to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,253.84 firm fixed-price delivery order contract is for the supply of Irbesartan 300 mg tablets. The contract has an ultimate completion date of February 26, 2025 and was awarded on February 25, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,432.74, is for the delivery of Irbesartan 300 mg tablets. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,993.00 firm fixed-price delivery order contract is for the supply of Irbesartan 150 mg tablets to support military healthcare programs. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,564.06, is for the provision of Irbesartan 300 mg tablets to support federal healthcare programs. It is a Firm Fixed Price contract with a completion date of February 11, 2025. The contract is not designated with a specific set-aside requirement, indicating open competition....
This federal contract award, valued at $11,048.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Irbesartan 300 mg tablets, a medication used to treat high blood pressure. The contract is a Firm Fixed Price Delivery Order with a completion date of January 16, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,637.97 Firm Fixed Price Delivery Order is for the supply of 90-count bottles of 300 mg Irbesartan tablets. The contract has an ultimate completion date of November 25, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D1050|SPE2DB24FH74Z, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order valued at $2,697.68, is for the supply of 4564986548 ! IRBESARTAN 150 MG TABLET 90S, a cardiovascular medication. The contract has a firm fixed price and an ultimate completion date of June 25, 2024. This award is part of Amerisourcebergen's Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $4,223.37 firm fixed price delivery order is for the supply of 4,564,960,650 Irbesartan 150 mg tablets in quantities of 90. The award has no set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,731.54 contract is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUT72
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Irbesartan 300 mg tablets, a cardiovascular medication, to support military healthcare programs. The contract has a ceiling value of $1,811.45 and a period of performance through March 4, 2025.

The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

This contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and the contract is being funded by the DLA, a defense agency responsible for providing logistics, acquisitions, and technical services to the U.S. military.

Generated 6/2/25, 9:44 AM